4
Changes in Ownership
Faeth Therapeutics, Inc. Filed Acc 0001567619-22-002935
Director bought 30,000 shares at an average $4.53 ($135,800)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Peyer James Director | 2022-02-03 | Purchase | +17,500 | $4.65 | $81,375 | 5,145,786 | I: show line 1 in the form |
| Peyer James Director | 2022-02-04 | Purchase | +2,500 | $4.45 | $11,125 | 5,148,286 | I: show line 2 in the form |
| Peyer James Director | 2022-02-08 | Purchase | +10,000 | $4.33 | $43,300 | 5,158,286 | I: show line 3 in the form |
| Open-market purchases · 30,000 sh · avg $4.53 · $135,800 | |||||||
Loading xslF345X03/doc1.xml…